Cite
HARVARD Citation
Larrey, E. et al. (2022). A standardized immunosuppressive regimen for patients who received liver transplantations treated with atezolizumab–bevacizumab to avoid graft rejection?. Liver transplantation. 28 (7), pp. 1262-1263. [Online].